Breast tumors are phenotypically diverse and are thus classified into five subtypes based on the corresponding gene expression patterns of epidermal growth factor receptor (EGFR) 2 (known as HER2/neu) (which is overexpressed in approximately 20% of all breast tumors), estrogen receptor-α (ER), and progesterone receptor (PgR) (Zhiyuan Hu et al. 2006; Sørlie et al. 2001). Here, EGFR is linked to breast neoplasm.